Abstract
This study evaluated the correlation of UGT1A1, OATP2 gene mutations and hyperbilirubinemia in newborns in Northern China. Gene mutations were analyzed at the 211 locus of UGT1A1 (Gly71Arg) and 388 locus of OATP2 (Asn130Asp). The 226 enrolled infants were divided into high, moderate, and low risk subgroups according to American Academy of Pediatrics guideline. Blood samples of the enrolled infants were collected for the analysis of the PCR-restriction fragment length polymorphism. The genotypes and allele frequencies of the polymorphisms were compared in each group. Both UGT1A1 and OATP2 gene mutations occur more often in high risk group and moderate risk group than in low risk group. The results suggested that Gly71Arg and Asn130Asp mutations in UGT1A1 and OATP2 genes might be involved in the development of hyperbilirubinemia in neonates.
References
Katar S. Glucose-6-phosphate dehydrogenase deficiency and kernicterus of South-East anatolia. Pediatr Hematol Oncol. 2007;29:284–6.
Kaga A, Ohkubo Y, Watanabe Y, et al. Development of icterus gravis in a preterm infant with G71R UGT1A1 polymorphism. BMC Res Notes. 2013;6:51.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Magnement of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004;56:682–9.
Fujiwara R, Chen S, Karin M, Tukey RH. Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia. Gastroenterology. 2012;142:109–18.e2.
Kilic I, Koseler A, Cakaloz I, Atalay E. Screening for G71R mutation of the UDP-glucuronosyltransferase 1 (UGT1A1) gene in neonates with pathologic and prolonged hyperbilirubinemia in Turkey. Int J Clin Pharmacol Ther. 2010;48:504–8.
Azlin I, Wong FL, Ezham M, Hafiza A, Ainoon O. Prevalence of uridine glucuronosyl transferase 1A1 (UGT1A1) mutations in Malay neonates with severe jaundice. Malays J Pathol. 2011;33:95–100.
Zhou YY, Lee LY, Ng SY, et al. UGT1A1 haplotype mutation among Asians in Singapore. Neonatology. 2009;96:150–5.
Fu W, Liu Y. Role of genetic factors in occurrence of neonatal jaundice in Guangxi region. Zhonghua Er Ke Za Zhi. 2005;43:743–7.
Montenegro-Miranda PS, Sneitz N, de Waart DR, et al. Ezetimibe: a biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia. Biochim Biophys Acta. 2012;1822:1223–9.
Acknowledgments
The authors thank Dr. Yang Meng for critical reading of this paper.
Contributions
JM: Research design, data verification, and manuscript preparation; LJ: Clinical procedure supervision and data summarization; YC: Data verification and statistical analysis; LY: Clinical sample collection and data recording; YX: Gene analysis. LY will act as guarantor for the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None.
Rights and permissions
About this article
Cite this article
Min, J., Jie, L., Caiyun, Y. et al. Gene Mutation in Neonatal Jaundice – Mutations in UGT1A1 and OATP2 Genes. Indian J Pediatr 83, 723–725 (2016). https://doi.org/10.1007/s12098-016-2064-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-016-2064-8